Apollo Hospitals Q4fy23 Pat Up 50 14 At Rs146crore Due To Lower Tax Burden In The Current Quarter

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Stock chart

Apollo Hospitals Q4FY23 PAT up 50.14% at Rs146crore due to lower tax burden in the current quarter

ri-calendar-2-lineMay 31, 2023

By: BlinkX Research Team

FbkFbkTwitterTelegram

Apollo  Hospitals reported 21.3% growth in net sales revenues for the March 2023 quarter on consolidated basis at Rs4,302 crore. Revenues were marginally up 0.91% on sequential basis. For the quarter, the revenues from the healthcare services were up 18.5% yoy at Rs2,227 crore. The revenues from retail health and diagnostics vertical were up 3% at Rs308 crore while revenues from digital and pharmacy distribution was up 30.8% at Rs1,799 crore.

While the operating profits for the quarter were up 10.87% overall at Rs329 crore, the net profits grew 50.14% on yoy basis to Rs146 crore. The operating profits growth was almost 50% yoy at Rs411 crore in the healthcare services business. However, the retail health and diagnostics vertical saw operating profits fall by nearly three-fourth while the digital health and pharmacy business actually dipped into an operating loss of Rs-83 crore. Net profit growth was largely on account of lower tax burden in the quarter.

Financial highlights for Mar-23 compared yoy and sequentially

 Apollo Hospitals    

Rs in Crore

Mar-23

Mar-22

YOY

Dec-22

QOQ

Total Income (Rs cr)

₹ 4,302

₹ 3,546

21.31%

₹ 4,264

0.91%

Operating Profit (Rs cr)

₹ 329

₹ 297

10.87%

₹ 352

-6.50%

Net Profit (Rs cr)

₹ 146

₹ 97

50.14%

₹ 162

-10.27%

 

 

 

 

 

 

Diluted EPS (Rs)

₹ 10.05

₹ 6.27

 

₹ 10.67

 

OPM

7.65%

8.37%

 

8.26%

 

Net Margins

3.39%

2.74%

 

3.81%

 

 

The operating margins tapered yoy from 8.37% to 7.65% due to higher operating costs and operating losses in the digital pharmacy business. Net margins improved at 3.39% compared to 2.74% in year ago period. Company declared a final dividend of Rs9 per share, with combined with the interim dividend of Rs6 per share came to total dividend of Rs15 per share.

Related News

News Thumbnail
Quarterly Result

BLS's Q2FY24 Financial Performance Review

2 mins read. November 6, 2023 at 08:56 AM

News Thumbnail
Quarterly Result

Interglobe Aviation's Q2FY24 Financial Performance Review

2 mins read. November 3, 2023 at 11:31 AM

News Thumbnail
Quarterly Result

Titan's Q2FY24 Financial Performance Review

2 mins read. November 3, 2023 at 10:59 AM

News Thumbnail
Quarterly Result

Zomato's Q2FY24 Financial Performance Review

3 mins read. November 3, 2023 at 09:50 AM

Related Blogs

Stock chartDemat Account

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025

0 people read

3 mins read . Aug 20, 2025

Stock chartMutual Fund

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025

0 people read

8 mins read . Aug 18, 2025

Download app

Access BlinkX
everywhere
across device

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions